Business Standard

US authorises J&J's single-dose Covid-19 vaccine for emergency use

Shipments to vaccination sites are expected to begin on Sunday or Monday

vaccine, pharma, coronavirus, medicine, drugs, medical research, covid, lab
Premium

Reuters
The US government authorised Johnson & Johnson’s single-dose Covid-19 vaccine, enabling millions more Americans to be vaccinated in the coming weeks and setting the vaccine up for additional approvals around the world.
 
The J&J vaccine is the third authorised in the United States, following ones from Pfizer/BioNTech and Moderna, both of which require two doses. Shipments to vaccination sites are expected to begin on Sunday or Monday.
 
US virus cases may stick at 70,000 a day, fears Fauci
 
The case baseline at 70,000 a day, needs to fall further before the US can confidently resume normal activities, said

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in